Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.
Krug, L. M.; Miller, V. A.; Kalemkerian, G. P.; Kraut, M. J.; Ng, K. K.; Heelan, R. T.; Pizzo, B. A.; Perez, W.; McClean, N.; Kris, M. G.; Annals of Oncology, 2000, vol. 11, issue 2, p 227, ISSN 09237534. ISBN 09237534.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef